News

Anthropic IPO Roughly Six Times Oversubscribed, Pricing on November 18 and Trading November 19 (November 16, 2026)

Anthropic's IPO drew about six times the shares on offer by the third day of its roadshow, and reports on November 16 put orders near seven times the available stock. The company plans to sell 825 million Class A shares at $70 to $78 each on Nasdaq under the ticker ANT; at the top of the range, the 801 million shares sold by the company alone would raise roughly $62.5 billion. Pricing is set for November 18, with trading expected to begin November 19.

Key takeaway

A company with $16.956 billion of quarterly revenue, a $567 million GAAP operating loss and a $23.291 billion net loss has drawn roughly six times the demand for its shares. That tells you about demand, not about value — and the real information does not arrive until the pricing date.

1. The event: from pushback to scramble in ten days ​

Anthropic publicly filed its updated prospectus on October 26, 2026. On November 10 it opened its roadshow with a price range of $70 to $78 per share, seeking a listing on the Nasdaq Global Select Market under the ticker "ANT."

On November 11, reports said institutional orders on the first day of the roadshow already covered the entire offering, and that underwriters were considering pricing above the stated range. The Financial Times reported that banks were discussing a valuation above $1.5 trillion.

On November 13, Bloomberg reported that orders had reached roughly six times the shares available, and that underwriters had told prospective buyers the allocation would favor existing shareholders, leaving some buyers with less than they expected.

On November 16 — today in Beijing — several outlets citing people familiar with the matter put orders close to seven times the available stock.

The published schedule has pricing on November 18 and the first day of trading on November 19. Anthropic would become the first AI company to enter the public market at a trillion-dollar-scale valuation.

2. The core facts ​

ItemFigureBasis and source
IssuerAnthropic, PBCProspectus
Listing venue / tickerNasdaq Global Select Market / ANTProspectus
Shares offered825 million Class A sharesProspectus
Of which sold by the company801 million sharesProspectus
Of which sold by existing holders23.6486 million sharesProceeds go to selling holders, not the company
Price range$70 to $78 per shareProspectus
Gross proceeds to the company at the top of the rangeAbout $62.478 billion801 million shares at $78
Underwriters' optionUp to 124 million additional shares within 30 daysProspectus
OversubscriptionAbout 6x (November 13)Bloomberg, citing people familiar
Latest readingClose to 7x (November 16)Media citing people familiar, not company-confirmed
Pricing date / first tradeNovember 18 / November 19Published schedule
Valuation path$2 trillion to $1.5 trillion to $1.0-1.4 trillionCompiled from media reports
Q3 revenue$16.956 billion, +1,127% year over year, roughly +47% sequentiallyProspectus
Q3 operating loss$567 million (Q2 was a $974 million operating profit)Prospectus
Q3 net loss$23.291 billionIncludes about $21.9 billion of non-cash fair value losses
Nine-month revenue$33.242 billion, +1,206.3% year over yearProspectus
Q3 compute and infrastructure cost$9.863 billionProspectus

3. What six times oversubscription does and does not tell you ​

It tells you demand is real. By the third day of the roadshow, orders stood at roughly six times the shares on offer. That gives underwriters room to price at the top of the range, or above it, without worrying about clearing the book.

It does not tell you the valuation is reasonable. Oversubscription is a demand signal, not a value judgment. The 2020-2021 IPO market produced many deals with double-digit oversubscription multiples, and a fair number of them traded below their offer price within a year. There is no stable relationship between the subscription multiple and long-run returns.

It does not tell you that retail buyers will get shares. Bloomberg's reporting said plainly that underwriters would prioritize existing shareholders and that some buyers would receive less than they expected. The other side of heavy oversubscription is extreme concentration in allocation.

4. Why this pricing matters more than OpenAI's round ​

On November 14 we covered OpenAI raising $15 billion at a $1.25 trillion pre-money valuation. That was a private-market price with no public book-building and no comparable reference.

Anthropic is different: it will be priced daily in public markets. The $70 to $78 range maps to a defined valuation band, and once pricing is set on November 18 the secondary market will produce a new price every day. For the first time, the question "what is an AI company worth" gets a continuously observable answer.

For OpenAI this cuts both ways. If Anthropic prices at the top of the range or above and trades well on day one, the $1.25 trillion private mark gains support. If it breaks issue on the first day, the 2027 window gets re-examined.

5. The financial picture: very fast revenue growth, a net loss inflated by non-cash items ​

Per the prospectus, Anthropic reported $16.956 billion of third-quarter revenue, up 1,127% year over year and about 47% sequentially, with $33.242 billion for the first nine months, up 1,206.3%. At the operating line, Q3 showed a $567 million loss, a reversal from a $974 million operating profit in Q2.

The $23.291 billion net loss needs to be decomposed. About $21.9 billion comes from fair value losses on convertible notes, derivative liabilities and SAFEs — non-cash accounting items that grow as the valuation rises, not operating cash outflows. Strip that out and the operating-scale loss is in the hundreds of millions.

This matters when reading IPO financials: the higher the valuation, the larger those fair value losses, and the larger the net loss. Using net loss to judge operating quality turns a valuation increase into an apparent deterioration in operations.

6. Three things to watch on November 18 ​

First, whether pricing lands inside or above $70 to $78. Pricing inside the range suggests underwriters want to leave secondary-market room; a raise suggests demand strong enough to give up first-day upside.

Second, the final proceeds and use of the overallotment option. Company proceeds are about $62.478 billion at the top of the range; exercising the full 124 million-share option adds more. The final number determines how long that capital can fund infrastructure buildout.

Third, how the first day of trading goes. A break of issue would immediately change the narrative across the AI complex; a strong debut would reinforce the "buy share with losses" logic. Neither is a judgment about long-run value, but both feed directly into the financing terms available to OpenAI and others still private.

7. Boundaries and inferences to avoid ​

  • Share counts, price range, proceeds and the overallotment option come from the S-1/A filed with the U.S. Securities and Exchange Commission, a public document;
  • The 6x and near-7x subscription figures come from media citing people familiar with the matter; the company has not confirmed them, and orders can be revised or withdrawn before pricing;
  • The report that underwriters are discussing a valuation above $1.5 trillion comes from the Financial Times and remains unresolved;
  • Revenue, operating loss and net loss are GAAP figures disclosed in the prospectus;
  • The $23.291 billion net loss includes about $21.9 billion of non-cash fair value losses; it is neither cash burn nor operating loss;
  • The valuation path is compiled from media reports with differing timing and definitions and should not be plotted as a single series;
  • This article does not forecast the pricing outcome, does not judge whether the valuation is reasonable, and is not investment advice.

8. Sources ​